Becker's Healthcare February 26, 2025
Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.
The investment brings the company’s U.S. manufacturing commitments to more than $50 billion since 2020, according to a Feb. 26 news release from the company.
...